Allie E Steinberger1, Linda M Youngwirth2, Se Eun Kim3, Naomi N Duke4, Asheley Skinner5, Alexander Gordee4, Maragatha Kuchibhatla4, Sarah Armstrong4, Keri A Seymour6. 1. Department of Surgery, Washington University in St. Louis, St. Louis, MO, USA. 2. Rex Bariatric Specialists, North Carolina Surgery, Raleigh, NC, USA. 3. Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC, USA. 4. Department of Pediatrics, Duke University School of Medicine, Durham, NC, USA. 5. Department of Medicine, Duke University School of Medicine, Durham, NC, USA. 6. Department of Surgery, Duke University, 407 Crutchfield St, Durham, NC, 27704, USA. keri.seymour@duke.edu.
Abstract
INTRODUCTION: Racial disparities exist in obesity prevalence and obesity-related comorbid conditions among youth. We hypothesized that non-White adolescents would have poorer 30-day outcomes after adolescent bariatric surgery. METHODS: Adolescent patients 19 years or younger who had bariatric surgery from January 2015 to December 2018 were identified in the Metabolic and Bariatric Surgery Accreditation and Quality Initiative Program datafiles. Patient characteristics and 30-day perioperative outcomes were compared across racial groups. Trends in utilization of adolescent bariatric surgery were evaluated by race and procedure. RESULTS: Bariatric surgery was performed in 3177 adolescents with a mean age of 17.9 years [standard deviation (SD) 1.1 years]. The majority of patients were White 71.5% (2,271), while only 16.4% (520) were Black, and 12.1% (386) were other. Black adolescents 42.7% (222) more commonly presented with a BMI >50kg/m2 compared to 28.4% (645) White and 27.2% (105) other. Baseline hypertension and sleep apnea were more common among Black adolescents than other racial groups (P< 0.05). Black adolescents with LRYGB comprised 4.6% (48) of procedures in 2015 and only 1.5% (11) in 2018. Clavien-Dindo complications and all-cause readmission rates were similar among racial groups. Mean BMI decrease after 30 days was greatest for Black patients after Roux-en-Y gastric bypass, with a loss of 3.1 BMI points (SD 1.5). CONCLUSIONS: Despite similar short-term outcomes, significant disparities exist for Black adolescents who qualify for bariatric surgery. Further investigation is warranted to better understand the racial differences that limit access and utilization of this safe and effective intervention.
INTRODUCTION: Racial disparities exist in obesity prevalence and obesity-related comorbid conditions among youth. We hypothesized that non-White adolescents would have poorer 30-day outcomes after adolescent bariatric surgery. METHODS: Adolescent patients 19 years or younger who had bariatric surgery from January 2015 to December 2018 were identified in the Metabolic and Bariatric Surgery Accreditation and Quality Initiative Program datafiles. Patient characteristics and 30-day perioperative outcomes were compared across racial groups. Trends in utilization of adolescent bariatric surgery were evaluated by race and procedure. RESULTS: Bariatric surgery was performed in 3177 adolescents with a mean age of 17.9 years [standard deviation (SD) 1.1 years]. The majority of patients were White 71.5% (2,271), while only 16.4% (520) were Black, and 12.1% (386) were other. Black adolescents 42.7% (222) more commonly presented with a BMI >50kg/m2 compared to 28.4% (645) White and 27.2% (105) other. Baseline hypertension and sleep apnea were more common among Black adolescents than other racial groups (P< 0.05). Black adolescents with LRYGB comprised 4.6% (48) of procedures in 2015 and only 1.5% (11) in 2018. Clavien-Dindo complications and all-cause readmission rates were similar among racial groups. Mean BMI decrease after 30 days was greatest for Black patients after Roux-en-Y gastric bypass, with a loss of 3.1 BMI points (SD 1.5). CONCLUSIONS: Despite similar short-term outcomes, significant disparities exist for Black adolescents who qualify for bariatric surgery. Further investigation is warranted to better understand the racial differences that limit access and utilization of this safe and effective intervention.
Authors: Sarah E Messiah; Gabriela Lopez-Mitnik; Deborah Winegar; Bintu Sherif; Kristopher L Arheart; Kirk W Reichard; Marc P Michalsky; Steven E Lipshultz; Tracie L Miller; Alan S Livingstone; Nestor de la Cruz-Muñoz Journal: World J Diabetes Date: 2013-10-15
Authors: Cynthia L Ogden; Margaret D Carroll; Hannah G Lawman; Cheryl D Fryar; Deanna Kruszon-Moran; Brian K Kit; Katherine M Flegal Journal: JAMA Date: 2016-06-07 Impact factor: 56.272
Authors: Cynthia L Ogden; Cheryl D Fryar; Craig M Hales; Margaret D Carroll; Yutaka Aoki; David S Freedman Journal: JAMA Date: 2018-06-19 Impact factor: 56.272
Authors: Eric L Cheung; Cynthia S Bell; Joyce P Samuel; Tim Poffenbarger; Karen McNiece Redwine; Joshua A Samuels Journal: Pediatrics Date: 2017-04-10 Impact factor: 7.124
Authors: Thomas H Inge; R Yates Coley; Lydia A Bazzano; Stavra A Xanthakos; Kathleen McTigue; David Arterburn; Neely Williams; Rob Wellman; Karen J Coleman; Anita Courcoulas; Nirav K Desai; Jane Anau; Roy Pardee; Sengwee Toh; Cheri Janning; Andrea Cook; Jessica Sturtevant; Casie Horgan; Ava J Zebrick; Marc Michalsky Journal: Surg Obes Relat Dis Date: 2018-04-17 Impact factor: 4.734
Authors: Paul H McClelland; Krystyna Kabata; Wojciech Gorecki; Antalya Jano; Michael E Zenilman; Piotr Gorecki Journal: Surg Endosc Date: 2022-07-25 Impact factor: 3.453